Experts are rapidly focused on retatrutide, a novel drug created by Eli Lilly, as a possible breakthrough in body reduction . Different than many previous approaches, retatrutide is a double -action compound targeting equally GLP-1 and GIP, substances that influence satiety and blood glucose balanc